TickerFactsScreenerDevelopers

LIGAND PHARMACEUTICALS INC (LGND) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$9.97M2010: -$29.30M2011: -$878.0K2012: $193.0K2013: $14.94M2014: $19.63M2015: $27.33M2016: $43.88M2017: $68.08M2018: $163.73M2019: $807.08M2020: $37.50M2021: $103.85M2022: $3.04M2023: $11.94M2024: -$22.61M2025: $41.00M$41.00M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$41.00M+281.4%
2024-$22.61M-289.3%
2023$11.94M+293.2%
2022$3.04M-97.1%
2021$103.85M+176.9%
2020$37.50M-95.4%
2019$807.08M+392.9%
2018$163.73M+140.5%
2017$68.08M+55.1%
2016$43.88M+60.6%
2015$27.33M+39.2%
2014$19.63M+31.3%
2013$14.94M+7642.5%
2012$193.0K+122.0%
2011-$878.0K+97.0%
2010-$29.30M-194.0%
2009-$9.97M—